Boston Scientific (BSX) Short Interest Ratio & Short Volume $98.73 +0.56 (+0.57%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Boston Scientific Short Interest DataBoston Scientific (BSX) has a short interest of 14.52 million shares. This marks a 17.76% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.5, indicating that it would take 2.5 days of the average trading volume of 5.48 million shares to cover all short positions.Current Short Interest14,520,000 sharesPrevious Short Interest12,330,000 sharesChange Vs. Previous Month+17.76%Dollar Volume Sold Short$1.30 billionShort Interest Ratio2.5 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares1,473,830,000 sharesPercentage of Shares Shorted0.99%Today's Trading Volume6,946,303 sharesAverage Trading Volume5,475,000 sharesToday's Volume Vs. Average127% Short Selling Boston Scientific? Sign up to receive the latest short interest report for Boston Scientific and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBSX Short Interest Over TimeBSX Days to Cover Over TimeBSX Percentage of Float Shorted Over Time Boston Scientific Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/202414,520,000 shares $1.30 billion +17.8%N/A2.5 $89.32 12/15/202412,330,000 shares $1.11 billion +0.7%N/A2.1 $90.11 11/30/202412,250,000 shares $1.11 billion +11.2%N/A2.1 $90.66 11/15/202411,020,000 shares $958.46 million -14.6%N/A1.8 $86.98 10/31/202412,910,000 shares $1.08 billion +14.2%N/A2.3 $84.02 10/15/202411,310,000 shares $981.37 million +3.6%N/A2 $86.77 Get the Latest News and Ratings for BSX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter. 9/30/202410,920,000 shares $915.10 million -10.5%N/A2 $83.80 9/15/202412,200,000 shares $1.02 billion +10.7%N/A2.2 $83.31 8/31/202411,020,000 shares $901.33 million +2.6%N/A2 $81.79 8/15/202410,740,000 shares $833.21 million -0.6%N/A1.9 $77.58 7/31/202410,800,000 shares $797.69 million -6.3%N/A1.8 $73.86 7/15/202411,530,000 shares $899.57 million +2.5%N/A1.9 $78.02 6/30/202411,250,000 shares $866.36 million -2.5%N/A1.9 $77.01 6/15/202411,540,000 shares $885.81 million -13.8%N/A1.9 $76.76 5/31/202413,380,000 shares $1.01 billion +8.5%N/A2.2 $75.59 5/15/202412,330,000 shares $917.97 million -11.6%N/A2 $74.45 4/30/202413,940,000 shares $1.00 billion +5.9%N/A2.2 $71.86 4/15/202413,160,000 shares $887.51 million +5.9%N/A2 $67.44 3/31/202412,430,000 shares $851.33 million +8.3%N/A1.9 $68.49 3/15/202411,480,000 shares $760.32 million +21.6%N/A1.8 $66.23 2/29/20249,440,000 shares $625.02 million -14.4%N/A1.5 $66.21 2/15/202411,030,000 shares $728.97 million +1.5%N/A1.7 $66.09 1/31/202410,870,000 shares $687.64 million -4.9%N/A1.6 $63.26 1/15/202411,430,000 shares $685.11 million +22.3%N/A1.7 $59.94 12/31/20239,350,000 shares $540.52 million -19.7%N/A1.3 $57.81 12/15/202311,640,000 shares $649.63 million +26.0%N/A1.6 $55.81 11/30/20239,240,000 shares $516.42 million -22.0%N/A1.2 $55.89 11/15/202311,850,000 shares $638.12 million +29.7%N/A1.4 $53.85 10/31/20239,140,000 shares $467.88 million -32.3%N/A1.1 $51.19 10/15/202313,490,000 shares $668.02 million -7.5%N/A1.6 $49.52 9/30/202314,580,000 shares $769.82 million +22.7%N/A1.9 $52.80 9/15/202311,880,000 shares $628.45 million -2.8%N/A1.6 $52.90 8/31/202312,220,000 shares $659.15 million +40.1%N/A1.7 $53.94 8/15/20238,720,000 shares $450.65 million +4.7%N/A1.2 $51.68 7/31/20238,330,000 shares $431.91 million +13.2%N/A1.1 $51.85 7/15/20237,360,000 shares $390.30 million -13.2%N/A0.9 $53.03 6/30/20238,480,000 shares $458.51 million -2.8%N/A1 $54.07 6/15/20238,720,000 shares $470.79 million -29.5%N/A1 $53.99 5/31/202312,360,000 shares $636.29 million -23.0%N/A1.3 $51.48 5/15/202316,050,000 shares $861.56 million -10.7%N/A1.8 $53.68 4/30/202317,970,000 shares $936.60 million +16.4%N/A2.1 $52.12 4/15/202315,440,000 shares $799.33 million +1.9%N/A1.9 $51.77 3/31/202315,160,000 shares $758.45 million +5.9%N/A1.9 $50.03 3/15/202314,310,000 shares $686.45 million +12.8%N/A2 $47.97 2/28/202312,690,000 shares $592.88 million +29.9%N/A1.8 $46.72 2/15/20239,770,000 shares $462.02 million -26.2%N/A1.5 $47.29 1/31/202313,230,000 shares $611.89 million -15.3%N/A2 $46.25 1/15/202315,610,000 shares $726.33 million +10.6%N/A2.3 $46.53 12/30/202214,110,000 shares $652.87 million -1.7%N/A2.1 $46.27 12/15/202214,350,000 shares $664.69 million +8.8%N/A2.1 $46.32 11/30/202213,190,000 shares $597.11 million +0.2%N/A1.9 $45.27 11/15/202213,170,000 shares $558.67 million -5.3%N/A1.9 $42.42 10/31/202213,910,000 shares $599.66 million -8.6%N/A2 $43.11 10/15/202215,220,000 shares $608.50 million -8.8%N/A2.2 $39.98 9/30/202216,690,000 shares $646.40 million +3.7%N/A2.5 $38.73 9/15/202216,100,000 shares $679.42 million +5.9%N/A2.4 $42.20 8/31/202215,210,000 shares $613.12 million -9.8%N/A2.1 $40.31 8/15/202216,860,000 shares $710.65 million +22.6%N/A2.2 $42.15 7/31/202213,750,000 shares $564.44 million -14.3%N/A1.7 $41.05 7/15/202216,040,000 shares $602.30 million -2.4%N/A1.9 $37.55 6/30/202216,440,000 shares $612.72 million -13.6%N/A1.9 $37.27 6/15/202219,020,000 shares $685.29 million +25.3%1.4%2.2 $36.03 5/31/202215,180,000 shares $622.53 million +1.2%1.1%1.8 $41.01 5/15/202215,000,000 shares $594.90 million +21.5%1.1%1.7 $39.66 4/30/202212,350,000 shares $520.06 million +3.2%0.9%1.4 $42.11 4/15/202211,970,000 shares $529.67 million -23.6%0.9%1.3 $44.25 3/31/202215,670,000 shares $694.02 million +13.4%1.1%1.7 $44.29 3/15/202213,820,000 shares $589.56 million -21.5%1.0%1.5 $42.66 2/28/202217,600,000 shares $777.39 million -0.3%1.3%1.9 $44.17 2/15/202217,650,000 shares $776.78 million -3.8%1.3%1.9 $44.01 1/31/202218,340,000 shares $786.79 million +19.1%1.3%2 $42.90 1/15/202215,400,000 shares $690.84 million +1.9%1.1%1.9 $44.86 12/31/202115,120,000 shares $642.30 million +11.5%1.1%2 $42.48 12/15/202113,560,000 shares $545.65 million -7.8%1.0%1.8 $40.24 11/30/202114,700,000 shares $559.63 million -6.4%1.0%2.1 $38.07 11/15/202115,710,000 shares $649.45 million -26.0%1.1%2.4 $41.34 10/29/202121,220,000 shares $915.22 million -6.0%1.5%3.3 $43.13 10/15/202122,570,000 shares $979.54 million -5.1%1.6%3.6 $43.40 9/30/202123,790,000 shares $1.03 billion +15.8%1.7%3.7 $43.39 9/15/202120,540,000 shares $924.51 million +2.7%1.5%3.2 $45.01 8/31/202120,000,000 shares $903 million +19.0%1.4%3.2 $45.15 8/13/202116,810,000 shares $745.19 million +17.9%1.2%2.6 $44.33 7/30/202114,260,000 shares $650.26 million +15.5%1.0%2.2 $45.60 7/15/202112,350,000 shares $520.68 million -2.8%N/A1.9 $42.16 6/30/202112,710,000 shares $543.48 million -5.2%N/A1.8 $42.76 6/15/202113,400,000 shares $572.85 million +17.5%N/A1.9 $42.75 5/28/202111,400,000 shares $485.07 million -2.9%N/A1.6 $42.55 5/14/202111,740,000 shares $488.50 million -29.4%N/A1.5 $41.61 4/30/202116,620,000 shares $732.94 million +13.8%N/A2 $44.10 4/15/202114,610,000 shares $579.58 million -3.2%N/A1.7 $39.67 3/31/202115,090,000 shares $587.91 million -15.1%N/A1.6 $38.96 3/15/202117,780,000 shares $690.75 million -0.2%N/A1.8 $38.85 2/26/202117,810,000 shares $706.52 million -2.3%N/A1.5 $39.67 2/12/202118,230,000 shares $708.60 million +26.8%N/A1.5 $38.87 1/29/202114,380,000 shares $522.57 million -6.6%N/A1.1 $36.34 1/15/202115,400,000 shares $556.86 million +2.2%N/A1.1 $36.16 12/31/202015,070,000 shares $535.74 million -7.8%N/A1.1 $35.55 12/15/202016,340,000 shares $546.57 million +33.7%N/A1.2 $33.45 11/30/202012,220,000 shares $410.59 million -5.8%N/A1 $33.60 11/15/202012,970,000 shares $492.60 million +6.6%N/A1.2 $37.98 10/30/202012,170,000 shares $407.70 million +5.6%N/A1.3 $33.50 10/15/202011,520,000 shares $467.94 million -10.8%N/A1.5 $40.62 9/30/202012,920,000 shares $493.67 million -20.5%N/A1.8 $38.21 9/15/202016,250,000 shares $666.58 million +9.5%N/A1.9 $41.02 8/31/202014,840,000 shares $608.74 million -9.9%N/A1.6 $41.02 8/14/202016,470,000 shares $644.97 million +5.2%N/A1.7 $39.16 7/31/202015,660,000 shares $604.01 million +5.2%N/A1.5 $38.57 7/15/202014,890,000 shares $546.46 million -12.8%N/A1.4 $36.70 6/30/202017,070,000 shares $599.33 million -8.4%N/A1.5 $35.11 6/15/202018,640,000 shares $668.62 million +9.3%N/A1.6 $35.87 5/29/202017,060,000 shares $648.11 million +52.3%N/A1.4 $37.99 5/15/202011,200,000 shares $390.10 million +8.6%N/A0.9 $34.83 4/30/202010,310,000 shares $386.42 million -14.1%N/A0.9 $37.48 4/15/202012,000,000 shares $417.48 million +21.7%N/A1 $34.79 3/31/20209,860,000 shares $363.83 million -31.1%N/A0.8 $36.90 3/13/202014,308,500 shares $526.98 million +25.2%N/A1.7 $36.83 2/28/202011,430,000 shares $295.24 million +9.2%N/A1.3 $25.83 2/14/202010,470,000 shares $368.33 million -19.2%N/A1.5 $35.18 1/31/202012,960,000 shares $510.49 million +11.6%N/A1.9 $39.39 BSX Short Interest - Frequently Asked Questions What is Boston Scientific's current short interest? Short interest is the volume of Boston Scientific shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 14,520,000 shares of BSX short. Learn More on Boston Scientific's current short interest. What is a good short interest ratio for Boston Scientific? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BSX shares currently have a short interest ratio of 2.0. Learn More on Boston Scientific's short interest ratio. Which institutional investors are shorting Boston Scientific? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Boston Scientific: Portman Square Capital LLP, JPMorgan Chase & Co., Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Readystate Asset Management LP, Point72 DIFC Ltd, Point72 Asset Management L.P., Parallax Volatility Advisers L.P., Garda Capital Partners LP, Verition Fund Management LLC, Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, BNP Paribas Financial Markets, Citigroup Inc., LMR Partners LLP, Genus Capital Management Inc., and Caas Capital Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Boston Scientific's short interest increasing or decreasing? Boston Scientific saw a increase in short interest in December. As of December 31st, there was short interest totaling 14,520,000 shares, an increase of 17.8% from the previous total of 12,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Boston Scientific's short interest compare to its competitors? Here is how the short interest of companies compare to Boston Scientific: Abbott Laboratories (0.83%), Intuitive Surgical, Inc. (1.24%), Stryker Co. (1.29%), Medtronic plc (0.77%), Becton, Dickinson and Company (1.29%), Edwards Lifesciences Co. (1.95%), IDEXX Laboratories, Inc. (1.85%), ResMed Inc. (5.39%), DexCom, Inc. (2.25%), STERIS plc (1.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Boston Scientific stock? Short selling BSX is an investing strategy that aims to generate trading profit from Boston Scientific as its price is falling. BSX shares are trading up $0.56 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Boston Scientific? A short squeeze for Boston Scientific occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BSX, which in turn drives the price of the stock up even further. How often is Boston Scientific's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BSX, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies ABT Short Squeeze ISRG Short Squeeze SYK Short Squeeze MDT Short Squeeze BDX Short Squeeze EW Short Squeeze IDXX Short Squeeze RMD Short Squeeze DXCM Short Squeeze STE Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:BSX) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boston Scientific Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Boston Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BSX Stock Alerts